Dicot Pharma AB (STO:DICOT)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.8940
+0.0010 (0.11%)
At close: Aug 28, 2025
0.11%
Market Cap1.79B
Revenue (ttm)n/a
Net Income (ttm)-78.10M
Shares Out2.01B
EPS (ttm)-0.06
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume9,403,842
Average Volume18,332,363
Open0.8940
Previous Close0.8930
Day's Range0.8500 - 0.9100
52-Week Range0.1528 - 1.0260
Beta1.67
RSI64.32
Earnings DateAug 22, 2025

About Dicot Pharma AB

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It is developing LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2015
Employees 3
Stock Exchange Nasdaq Stockholm
Ticker Symbol DICOT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.